Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial

Abroad (travel likely)RecruitingPHASE2

Conditions

Lung Non-Small Cell Carcinoma · Stage IIIB Lung Cancer AJCC v8 · Stage IV Lung Cancer AJCC v8

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

CTCA at Western Regional Medical Center, Goodyear, Arizona, United States
Contact: Study coordinator (Ravi Salgia) · rsalgia@coh.org · 626-218-9200
Contact: Principal Investigator (Ravi Salgia)
City of Hope Corona, Corona, California, United States
Contact: Study coordinator (Ravi Salgia) · rsalgia@coh.org · 626-218-9200
Contact: Principal Investigator (Ravi Salgia)
City of Hope Medical Center, Duarte, California, United States
Contact: Study coordinator (Ravi Salgia) · rsalgia@coh.org · 626-218-9200
Contact: Principal Investigator (Ravi Salgia)
City of Hope Seacliff, Huntington Beach, California, United States
Contact: Study coordinator (Ravi Salgia) · rsalgia@coh.org · 626-218-9200
Contact: Principal Investigator (Ravi Salgia)
City of Hope at Irvine Lennar, Irvine, California, United States
Contact: Study coordinator (Ravi Salgia) · rsalgia@coh.org · 626-218-9200
Contact: Principal Investigator (Ravi Salgia)
City of Hope Antelope Valley, Lancaster, California, United States
Contact: Study coordinator (Ravi Salgia) · rsalgia@coh.org · 626-218-9200
Contact: Principal Investigator (Ravi Salgia)
City of Hope at Long Beach Elm, Long Beach, California, United States
Contact: Study coordinator (Ravi Salgia) · rsalgia@coh.org · 626-218-9200
Contact: Principal Investigator (Ravi Salgia)
City of Hope at Newport Beach Fashion Island, Newport Beach, California, United States
Contact: Study coordinator (Ravi Salgia) · rsalgia@coh.org · 626-218-9200
Contact: Principal Investigator (Ravi Salgia)
City of Hope South Pasadena, South Pasadena, California, United States
Contact: Study coordinator (Ravi Salgia) · rsalgia@coh.org · 626-218-9200
Contact: Principal Investigator (Ravi Salgia)
City of Hope South Bay, Torrance, California, United States
Contact: Study coordinator (Ravi Salgia) · rsalgia@coh.org · 626-218-9200
Contact: Principal Investigator (Ravi Salgia)
City of Hope Upland, Upland, California, United States
Contact: Study coordinator (Ravi Salgia) · rsalgia@coh.org · 626-218-9200
Contact: Principal Investigator (Ravi Salgia)
City of Hope Atlanta Cancer Center, Newnan, Georgia, United States
Contact: Study coordinator (Ravi Salgia) · rsalgia@coh.org · 626-218-9200
Contact: Principal Investigator (Ravi Salgia)
City of Hope at Chicago, Zion, Illinois, United States
Contact: Study coordinator (Ravi Salgia) · rsalgia@coh.org · 626-218-9200
Contact: Principal Investigator (Ravi Salgia)

Study leads

Ravi Salgia, MD
Principal Investigator
City of Hope Medical Center
Jyoti Malhotra [Co-PI], MD
Principal Investigator
City of Hope Medical Center

View source on ClinicalTrials.gov